Rabasa, Melesia V.
HRN: 10-17-72 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CEFTRIAXONE 1G (VIAL)
04/25/2022
04/26/2022
IV
2gms
OD
CAP MR
Waiting Final Action